Singular Genomics Systems, Inc. (OMIC): Price and Financial Metrics Recent IPO
GET POWR RATINGS... FREE!
OMIC Stock Price Chart Interactive Chart >
OMIC Price/Volume Stats
|Current price||$18.05||52-week high||$33.37|
|Prev. close||$18.07||52-week low||$15.65|
|Day high||$18.40||Avg. volume||221,700|
|50-day MA||$0.00||Dividend yield||N/A|
|200-day MA||$0.00||Market Cap||1.25B|
Singular Genomics Systems, Inc. (OMIC) Company Bio
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. It manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits; and offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. The company was incorporated in 2016 and is headquartered in La Jolla, California.
OMIC Latest News Stream
|Loading, please wait...|
OMIC Latest Social Stream
View Full OMIC Social Stream
Latest OMIC News From Around the Web
Below are the latest news stories about Singular Genomics Systems Inc that investors may wish to consider to help them evaluate OMIC as an investment opportunity.
The IPO activity this year continues a heavy momentum built up last year – when despite the corona crisis and the economic dislocations, the market saw record breaking IPO activity, with 407 new public offerings. It’s an example of the stock market’s dynamism, and the confidence of both company managers and investors that stocks are the place to find returns. This brings us to Goldman Sachs. The banking firm’s stock analysts have been looking for the equities primed to gain in current conditions.
Singular Genomics Systems, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
LA JOLLA, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (“Singular Genomics”), a company focused on delivering genomic technologies for the advancement of science and medicine, today announced the closing of its initial public offering of 11,730,000 shares of its common stock, which includes the full exercise of the underwriters' option to purchase 1,530,000 additional shares of common stock, at a public offering price of $22.00 per share. All of the shares of common
Singular Genomics Systems, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock
LA JOLLA, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (“Singular Genomics”), a company focused on delivering genomic technologies for the advancement of science and medicine, today announced the pricing of its upsized initial public offering of 10,200,000 shares of its common stock at an initial public offering price of $22.00 per share. All of the shares of common stock are being offered by Singular Genomics. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Singular Genomics, are expected to be $224.4 million. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “OMIC” on May 27, 2021. The offering is expected to close on June 1...
OMIC Price Returns